Misoprostol in the treatment of chronic refractory constipation: Results of a long-term open label trial

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 6, 1997, Pages 1059-1066

  Roarty, T P ^a,b   Weber, F ^a   Soykan, I ^b   McCallum, R W ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; DOCUSATE SODIUM; LAXATIVE; MISOPROSTOL;

ABDOMINAL CRAMP; ADULT; ARTICLE; BLADDER PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON MOTILITY; COLONOSCOPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 0030786769     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00237.x     Document Type: Article

References (25)

1. Isselbacher KJ. The role of arachidonic acid metabolites in gastrointestinal homeostasis. Drugs 1987; 33 (Suppl. 1): 38-46.
2. Bennett A, Stamford IF, Stockley HL. Estimation and characterization of prostaglandins in the human gastrointestinal tract. Br J Pharmacol 1977; 61: 579-86.
3. Monk JP, Clissod SP. Misoprostol: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of peptic ulcer disease. Drugs 1987: 33: 1-30.
4. Kimberg DV. Field M, Johnson J. Henderson A, Gershon E. Stimulation of intestinal mucosal adenylcyclase by cholera enterotoxin and prostaglandins. J Clin Invest 1971: 50: 1218-30.
5. Kimbert DV, Field M, Gershon E, Henderson A. Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP. J Clin Invest 1974; 53: 941-9.
6. Bennet A. Cholera and prostaglandins. Nature 1971: 231: 536 (Letter).
7. Peterson JW, Ochoa LG. Role of prostaglandins and cAMP in the secretory effects of cholera toxin. Science 1989; 245: 867-9.
8. Wald A, Gotterer GS, Rajendra GR, Turjman NA, Hendrix TR. Effect of indomethacin on cholera-induced fluid movement, unidirectional sodium fluxes, and intestinal cAMP. Gastroenterology 1977: 72: 106-10.
9. Robert A, Nezamis JE, Lancaster C, Hanchar AJ, Klepper MS. Enteropooling assay: a test for diarrhea produced by prostaglandins. Prostaglandins 1976; 11: 809-29.
10. Staumont G, Fioramonti J, Frexinos J, Bueno L. Changes in colonic motility induced by sennosides in dogs: evidence of prostaglandin mediation. Gut 1988; 29: 1180-7.
11. Riviere PJ, Farmer SC. Burks TF, Porreca F. Prostaglandin E2induced diarrhea in mice: importance of colonic secretion. J Pharmacol Exp Ther 1991; 256: 547-52.
12. Rush BD, Ruwart MJ. The role of accelerated colonic transit in prostaglandin induced diarrhoea and its inhibition by prostacyclin. Br J Pharmacol 1984: 83: 157-9.
13. Fioramonti J, Staumont G, Garcia-Villar R. Bueno L. Effect of sennosides on colon motility in dogs. Pharmacology 1988: 36: 23-30.
14. Thor P, Konturek JW, Konturek SJ, Andersen JH. Role of prostaglandins in control of intestinal motility. Am J Physiol 1985: 248: G353-9.
15. Tollstrom T, Hellstrom PM, Johanson C, Pernow B, Effects of prostaglandins E2 and F2a on motility of the small intestine in man. Dig Dis Sci 1988: 33: 552-7.
16. Soffer EE, Metcalf A, Launspach J. Misoprostol is effective treatment for patients with severe chronic constipation. Dig Dis Sci 1994; 39: 929-33.
17. Metcalf AM, Philips SF, Zinsmcistcr AR, et al. Simplified assessment of segmental colonic transit. Gastroenterology 1987; 92: 40-7.
18. Glantz SA. Primer of Biostatistics, 4th edn. New York: McGraw Hill, Health Professions Divison, 1997.
19. Delvarux M, Staumont G, Fioramonti J, Bueno L, Fexinos. Alterations of colonic motility after oral administration of prostaglandin El analogue misoprostol in man. J Gastrointest Mot 1992; 4: 33-8.
20. Hunt RH, Dilawari JB, Misiewicz JJ. The effect of intravenous prostaglandin F2 and E2 on the motility of the sigmoid colon. Gut 1975; 16: 47-9.
21. Theodoru V, Fioramonti J, Buseno L. Involvement of peripheral and central motor and secretory components in the action of a prostaglandin E2 analogue on colonic transit in rats. J Gastrointestinal Mot 1992; 4: 107-12.
22. Burakoff R, Nastos E. Won S. Effects of PGF and of indomethacin on rabbit small and large intestinal motility in vivo. Am J Physiol 1990; 258: G231-7.
23. Burakoff R, Percy H. Studies in vivo and in vitro on effects of PGE2 on colonic motility in rabbits. Am J Physiol 1992; 262: G23-9.
24. Milton-Thompson GJ, Cummings JH, Newman A, Billings A, Misiewicz JJ. Colonic and small intestinal responsiveness to intravenous prostaglandin F2 and E2 in man. Gut 1975; 16: 42-6.
25. McCallum RW. Clinical pharmacology forum: motility agents and the gastrointestinal tract. Am J Med Sci 1996; 312: 19-26.